These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 33669447

  • 41. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
    Cao X, Dang L, Zheng X, Lu Y, Lu Y, Ji R, Zhang T, Ruan X, Zhi J, Hou X, Yi X, Li MJ, Gu T, Gao M, Zhang L, Chen Y.
    Thyroid; 2019 Jun; 29(6):809-823. PubMed ID: 30924726
    [Abstract] [Full Text] [Related]

  • 42. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W, Chen Y, Gong Y, Dong T, Zhang B, Gao W.
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [Abstract] [Full Text] [Related]

  • 43. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
    Zhu X, Park S, Lee WK, Cheng SY.
    Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080
    [Abstract] [Full Text] [Related]

  • 44. 1,25‑Dihydroxyvitamin D3 enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin‑induced apoptosis by increasing the generation of reactive oxygen species.
    Zhang T, He L, Sun W, Qin Y, Zhang P, Zhang H.
    Mol Med Rep; 2019 Sep; 20(3):2641-2648. PubMed ID: 31524258
    [Abstract] [Full Text] [Related]

  • 45. Synergy between isobavachalcone and doxorubicin suppressed the progression of anaplastic thyroid cancer through ferroptosis activation.
    Lin S, Cai H, Song X.
    Braz J Med Biol Res; 2024 Sep; 57():e13679. PubMed ID: 39166605
    [Abstract] [Full Text] [Related]

  • 46. miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
    Shao M, Geng Y, Lu P, Xi Y, Wei S, Wang L, Fan Q, Ma W.
    Biochem Biophys Res Commun; 2015 Sep 04; 464(4):1309-1313. PubMed ID: 26231799
    [Abstract] [Full Text] [Related]

  • 47. The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model.
    Häfliger P, Graff J, Rubin M, Stooss A, Dettmer MS, Altmann KH, Gertsch J, Charles RP.
    J Exp Clin Cancer Res; 2018 Sep 21; 37(1):234. PubMed ID: 30241549
    [Abstract] [Full Text] [Related]

  • 48. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Liao Y, Hua Y, Li Y, Zhang C, Yu W, Guo P, Zou K, Li W, Sun Y, Wang R, Zuo Y, Sui S, Tian C, Hao J, Chen M, Hu S, Chen M, Long Q, Wang X, Zou L, Xie F, Guo W, Deng W.
    Cell Death Differ; 2021 Apr 21; 28(4):1347-1363. PubMed ID: 33162555
    [Abstract] [Full Text] [Related]

  • 49. YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells.
    Cheng SM, Chang YC, Liu CY, Lee JY, Chan HH, Kuo CW, Lin KY, Tsai SL, Chen SH, Li CF, Leung E, Kanwar JR, Huang CC, Chang JY, Cheung CH.
    Br J Pharmacol; 2015 Jan 21; 172(1):214-34. PubMed ID: 25220225
    [Abstract] [Full Text] [Related]

  • 50. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
    Zhang W, Liu Y, Li YF, Yue Y, Yang X, Peng L.
    Cell Physiol Biochem; 2016 Jan 21; 38(6):2426-37. PubMed ID: 27287458
    [Abstract] [Full Text] [Related]

  • 51. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells.
    Zhang L, Cheng X, Gao Y, Bao J, Guan H, Lu R, Yu H, Xu Q, Sun Y.
    Food Funct; 2016 Jan 21; 7(1):315-25. PubMed ID: 26442630
    [Abstract] [Full Text] [Related]

  • 52. Protective effects of Nigella sativa extract against H2 O2 -induced cell death through the inhibition of DNA damage and cell cycle arrest in human umbilical vein endothelial cells (HUVECs).
    Farshori NN, Saquib Q, Siddiqui MA, Al-Oqail MM, Al-Sheddi ES, Al-Massarani SM, Al-Khedhairy AA.
    J Appl Toxicol; 2021 May 21; 41(5):820-831. PubMed ID: 33305432
    [Abstract] [Full Text] [Related]

  • 53. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F, Zhu Q, Lu L, Sun S, Huang Y, Zhang J, Liu Z, Miao Y, Jiao X, Chen D.
    Oncol Res; 2020 Sep 01; 28(4):345-355. PubMed ID: 32138807
    [Abstract] [Full Text] [Related]

  • 54. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.
    Tao YF, Lu J, Du XJ, Sun LC, Zhao X, Peng L, Cao L, Xiao PF, Pang L, Wu D, Wang N, Feng X, Li YH, Ni J, Wang J, Pan J.
    BMC Cancer; 2012 Dec 26; 12():619. PubMed ID: 23267699
    [Abstract] [Full Text] [Related]

  • 55. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M, Müller S, Britten M, Worm K, Schmid KW, Mann K, Fuhrer D.
    BMC Cancer; 2015 Mar 26; 15():184. PubMed ID: 25879531
    [Abstract] [Full Text] [Related]

  • 56. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.
    Sachita K, Yu HJ, Yun JW, Lee JS, Cho SD.
    J Oral Pathol Med; 2015 Nov 26; 44(10):785-91. PubMed ID: 25475012
    [Abstract] [Full Text] [Related]

  • 57. Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells.
    Hua SC, Chang TC, Chen HR, Lu CH, Liu YW, Chen SH, Yu HI, Chang YP, Lee YR.
    Pharm Res; 2012 Jul 26; 29(7):1990-2005. PubMed ID: 22477067
    [Abstract] [Full Text] [Related]

  • 58. The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity.
    Winter GE, Radic B, Mayor-Ruiz C, Blomen VA, Trefzer C, Kandasamy RK, Huber KVM, Gridling M, Chen D, Klampfl T, Kralovics R, Kubicek S, Fernandez-Capetillo O, Brummelkamp TR, Superti-Furga G.
    Nat Chem Biol; 2014 Sep 26; 10(9):768-773. PubMed ID: 25064833
    [Abstract] [Full Text] [Related]

  • 59. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells.
    de Souza Grinevicius VM, Kviecinski MR, Santos Mota NS, Ourique F, Porfirio Will Castro LS, Andreguetti RR, Gomes Correia JF, Filho DW, Pich CT, Pedrosa RC.
    J Ethnopharmacol; 2016 Aug 02; 189():139-47. PubMed ID: 27178634
    [Abstract] [Full Text] [Related]

  • 60. Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity.
    Zhu X, Zhao L, Doolittle WKL, Cheng SY.
    Endocr Relat Cancer; 2023 Jun 01; 30(6):. PubMed ID: 36939877
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.